ArticleFrontiers in oncology2022

Assessing the robustness of radiomics/deep learning approach in the identification of efficacy of anti-PD-1 treatment in advanced or metastatic non-small cell lung carcinoma patients.

Qianqian Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.